LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Normalized Growth Rate Inhibition Value Standard Error of the Mean for Normalized Growth Rate Inhibition Value
Hs 578T Brivanib
1.11
uM
LJP5
0.9335 0.0075 0.9364 0.0035
Hs 578T Brivanib
3.33
uM
LJP5
0.9252 0.0056 0.9281 0.0031
Hs 578T Brivanib
10
uM
LJP5
0.7916 0.0506 0.7967 0.0319
Hs 578T CHIR-99021
0.04
uM
LJP6
0.9677 0.0104 0.9697 0.0079
Hs 578T CHIR-99021
0.12
uM
LJP6
0.9616 0.0063 0.9636 0.0028
Hs 578T CHIR-99021
0.37
uM
LJP6
0.9629 0.0086 0.9623 0.0105
Hs 578T CHIR-99021
1.11
uM
LJP6
0.9148 0.0305 0.9112 0.0340
Hs 578T CHIR-99021
3.33
uM
LJP6
0.9056 0.0096 0.9066 0.0105
Hs 578T CHIR-99021
10
uM
LJP6
0.5739 0.0487 0.5247 0.0798
Hs 578T Linifanib
0.04
uM
LJP6
0.9960 0.0056 0.9952 0.0062
Hs 578T Linifanib
0.12
uM
LJP6
0.9791 0.0044 0.9790 0.0061
Hs 578T Linifanib
0.37
uM
LJP6
0.9721 0.0117 0.9710 0.0145
Hs 578T Linifanib
1.11
uM
LJP6
0.9693 0.0079 0.9694 0.0086
Hs 578T Linifanib
3.33
uM
LJP6
0.9472 0.0094 0.9497 0.0040
Hs 578T Linifanib
10
uM
LJP6
0.7103 0.0869 0.7014 0.0751
Hs 578T PIK-93
0.04
uM
LJP5
1.0145 0.0043 1.0134 0.0040
Hs 578T PIK-93
0.12
uM
LJP5
1.0091 0.0118 1.0109 0.0118
Hs 578T PIK-93
0.37
uM
LJP5
0.9827 0.0366 0.9898 0.0326
Hs 578T PIK-93
1.11
uM
LJP5
0.9173 0.0643 0.9294 0.0538
Hs 578T PIK-93
3.33
uM
LJP5
0.6175 0.0692 0.5852 0.0938
Hs 578T PIK-93
10
uM
LJP5
0.3236 0.0583 0.1625 0.1103
Hs 578T Dactolisib
0.04
uM
LJP5
0.3775 0.0552 0.2613 0.0388
Hs 578T Dactolisib
0.12
uM
LJP5
0.3394 0.0595 0.1973 0.0451
Hs 578T Dactolisib
0.37
uM
LJP5
0.2904 0.0598 0.1093 0.0502
Hs 578T Dactolisib
1.11
uM
LJP5
0.3027 0.0591 0.1317 0.0620